Literature DB >> 26701184

Low-Density Lipoprotein Cholesterol Level and Statin Therapy in Patients With Acute Myocardial Infarction (Cholesterol Paradox).

Tsuyoshi Nozue1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26701184     DOI： 10.1253/circj.CJ-15-1320

Source DB:  PubMed          Journal:  Circ J        ISSN： 1346-9843            Impact factor:   2.993


× No keyword cloud information.
  4 in total

1.  Admission Low-Density Lipoprotein Cholesterol Stratified by Circulating CD14++CD16+ Monocytes and Risk for Recurrent Cardiovascular Events Following ST Elevation Myocardial Infarction: Lipid Paradox Revised.

Authors:  Shaozhuang Dong; Wenjie Ji; Shan Zeng; Jun Miao; Lifang Yan; Xinlin Liu; Junxiang Liu; Xin Zhou; Qing Yang
Journal:  J Cardiovasc Transl Res       Date:  2020-06-18       Impact factor: 4.132

2.  Low-density lipoprotein cholesterol and survival in pulmonary arterial hypertension.

Authors:  Grzegorz Kopeć; Marcin Waligóra; Anna Tyrka; Kamil Jonas; Michael J Pencina; Tomasz Zdrojewski; Deddo Moertl; Jakub Stokwiszewski; Paweł Zagożdżon; Piotr Podolec
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

3.  The Lipid Paradox is present in ST-elevation but not in non-ST-elevation myocardial infarction patients: Insights from the Singapore Myocardial Infarction Registry.

Authors:  Ching-Hui Sia; Huili Zheng; Andrew Fu-Wah Ho; Heerajnarain Bulluck; Jun Chong; David Foo; Ling-Li Foo; Patrick Zhan Yun Lim; Boon Wah Liew; Huay-Cheem Tan; Tiong-Cheng Yeo; Terrance Siang Jin Chua; Mark Yan-Yee Chan; Derek J Hausenloy
Journal:  Sci Rep       Date:  2020-04-22       Impact factor: 4.379

4.  Are there sex differences in the effect of type 2 diabetes in the incidence and outcomes of myocardial infarction? A matched-pair analysis using hospital discharge data.

Authors:  Ana Lopez-de-Andres; Rodrigo Jimenez-Garcia; Valentin Hernández-Barrera; Jose M de Miguel-Yanes; Romana Albaladejo-Vicente; Rosa Villanueva-Orbaiz; David Carabantes-Alarcon; Jose J Zamorano-Leon; Marta Lopez-Herranz; Javier de Miguel-Diez
Journal:  Cardiovasc Diabetol       Date:  2021-04-22       Impact factor: 9.951
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.